|
Originally published In Press as doi:10.1074/jbc.M207519200 on August 28, 2002
J. Biol. Chem., Vol. 277, Issue 44, 41756-41761, November 1, 2002
Ionizing Radiation Activates Nuclear Protein
Phosphatase-1 by ATM-dependent Dephosphorylation*
Chang Y.
Guo ,
David L.
Brautigan§, and
James M.
Larner ¶
From the Department of Radiation Oncology, University
of Virginia Health System, Charlottesville, Virginia 22908 and
§ Center for Cell Signaling, University of Virginia School
of Medicine, Charlottesville, Virginia 22908
Received for publication, July 25, 2002, and in revised form, August 25, 2002
 |
ABSTRACT |
Ionizing radiation (IR) is known to activate
multiple signaling pathways, resulting in diverse stress responses
including apoptosis, cell cycle arrest, and gene induction.
IR-activated cell cycle checkpoints are regulated by Ser/Thr
phosphorylation, so we tested to see if protein phosphatases were
targets of an IR-activated damage-sensing pathway. Jurkat cells were
subjected to IR or sham radiation followed by brief
32P metabolic labeling. Nuclear extracts were
subjected to microcystin affinity chromatography to recover
phosphatases, and the proteins were analyzed by two-dimensional gel
electrophoresis. Protein sequencing revealed that the microcystin-bound
proteins with the greatest reduction in 32P intensity
following IR were the and isoforms of protein phosphatase 1 (PP1). Both of these PP1 isoforms contain an
Arg-Pro-Ile/Val-Thr-Pro-Pro-Arg sequence near the C terminus, a known
site of phosphorylation by Cdc/Cdk kinases, and phosphorylation
attenuates phosphatase activity. In wild-type Jurkat cells or ataxia
telangiectasia (AT) cells that are stably transfected with full-length
ATM kinase, IR resulted in net dephosphorylation of this site in PP1
and produced activation of PP1. However, in AT cells that are deficient
in ATM, IR failed to induce dephosphorylation or activation of PP1. IR-induced PP1 activation in the nucleus may be a critical component in
an ATM-mediated pathway controlling checkpoint activation.
 |
INTRODUCTION |
Ionizing radiation (IR)1
is known to activate multiple signaling pathways resulting in diverse
stress responses including apoptosis, cell cycle arrest, and gene
induction (1, 2). Many of these responses are controlled by
phosphorylation and dephosphorylation of Ser and Thr residues in
proteins. PP1 is a major protein Ser/Thr phosphatase conserved among
eukaryotic species that regulates a variety of key steps in metabolism,
replication, transcription, and the cell cycle (3-6). PP1 is required
for completion of mitosis in many eukaryotic organisms. For example, in
Aspergillus nidulans and in Schizosaccharomyces
pombe proteins with 80% identity to mammalian PP1 are required
for separation of daughter nuclei, completion of anaphase, and
chromosome segregation (7, 8). The Aspergillus mutant
bimG11, which encodes a protein similar to mammalian PP1,
prevents normal mitotic progression and normal polar growth. Expression
of mammalian PP1 fully complements the bimG11 phenotype.
Additionally, microinjection of neutralizing PP1 antibody into
mammalian cells in early mitosis causes metaphase arrest (9, 10).
Although PP1 is required for cell cycle progression, few substrates of
PP1 have been identified, and therefore, its role in these processes
remains poorly defined. Several lines of evidence suggest that in the
absence of DNA damage, Rb is regulated by PP1. Mitotic extracts
dephosphorylate Rb in the absence but not the presence of inhibitor 2, a protein specific for PP1 (11). Microinjection of PP1 into
G1 cells results in accumulation of dephosphorylated Rb and
inhibition of S phase progression (12). Other potential PP1 substrates
that regulate mitotic progression include Cdk1 and lamin B (13), the
dephosphorylation of which may be necessary for the formation of the
nuclear envelope. Histones H1 and H3 may also be dephosphorylated by
PP1 in mitosis (14-16).
PP1 plays an important role in cell cycle progression and is a
potentially important downstream effector of IR-stimulated damage-sensing pathways resulting in checkpoint activation. Here we
show that IR causes dephosphorylation of a Thr site in PP1 catalytic
subunit (PP1c) resulting in activation of PP1. The IR-induced dephosphorylation of this site is shown to be dependent on ATM (mutated
in ataxia telangiectasia), the gene product that is deficient in the
human autosomal recessive disease.
 |
MATERIALS AND METHODS |
Cell Culture--
Jurkat cells (a human T cell lymphoma cell
line) were grown in RPMI 1640 medium (Life Technologies, Inc.) with
penicillin and streptomycin and 10% fetal bovine serum.
FT/pEBS7 and FT/pEBS7-YZ5 cells were both derived from the AT22IJE-T
line (17), an immortalized fibroblast line containing a homozygous
frameshift mutation at codon 762 of the ATM gene.
AT22IJE-T cells were transfected with the mammalian expression vector
pEBS7 (18) containing either the hygromycin resistance marker to yield
FT/pEBS7 cells or with full-length ATM open reading
frame to yield FT/pEBS7-YZ5 cells. FT/pEBS7 and FT/pEBS7-YZ5
were generously provided by Y. Shiloh (Tel Aviv University) and grown
in Dulbecco's modified Eagle's medium with 15% fetal bovine serum
and 100 µg/ml hygromycin B. All cells were in an exponential growth
phase at the time of radiation.
Radiation Treatment--
Cell cultures were irradiated with a
Varian linear accelerator at a dose rate of 9 Gy per min. During
irradiation, the cultures were maintained in a container designed to
mimic the conditions of the cell culture incubator (5% CO2
and 95% air at 37 °C).
Preparation of Nuclear Extracts--
Cells were collected by
centrifugation in an ice-cold preparation buffer consisting of 20 mM HEPES pH 7.4, 110 mM potassium acetate, 2 mM magnesium acetate, and 5 mM EGTA. The cell
pellet was resuspended in the same buffer containing 1 µg/ml
aprotinin, 1 mM PefablocTM, 0.2 mM
PMSF, and 1 mM dithiothreitol at 5 × 105
cells/ml. Digitonin was added to a final concentration of 50 µg/ml to
permeabilize the plasma membrane and release the cytosol. The cell
suspension was placed on ice for 5 min and then diluted 10-fold in
complete preparation buffer. Following centrifugation, the pellet
containing intact nuclei was extracted with either nuclear lysis buffer
(1% Nonidet P-40, 150 mM NaCl, 10 mM sodium phosphate, pH 7.2, 2 mM EDTA, 50 mM sodium
fluoride, 0.2 mM sodium vanadate, 1 mM PMSF,
and 1 µg/ml aprotinin) or for the PP1 activity assay lysis buffer
(1% Triton X-100, 150 mM NaCl, 10 mM Tris-Cl, pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0, 0.2 mM sodium vanadate, and 0.2 mM PMSF).
Western Analyses--
Samples (80-100 µg of protein) were run
on 12% SDS-polyacrylamide gels and transferred (with
Tris/glycine/methanol buffer, 100 V for 1 h) to nitrocellulose.
Reactive proteins were detected with horseradish peroxidase-conjugated
antibodies and detected by chemiluminescence. The following commercial
antibodies were used: anti-phospho-PP1 (Thr-320) antibody (Cell
Signaling Technology), anti-PP1c (Santa Cruz Biotechnology, Inc.),
and anti-Cdk2 (Upstate Biotechnology). Anti-PP1 and anti-PP1 were
raised and purified against synthetic peptides corresponding to the
C-terminal regions of the and isoforms, respectively.
Microcystin Affinity Purification--
80 µl of a 50% slurry
of microcystin-agarose (Upstate Biotechnology Inc.) was added to
nuclear extract containing 4.0 mg of total protein and incubated for
3 h at 4 °C, after which the beads were washed three times with
ice-cold nuclear lysis buffer. The protein was then dissociated from
the beads with SDS boiling sample buffer and assayed by two-dimensional
gel analysis.
Histone H1 Kinase Assays--
Cells were collected, washed with
cold phosphate-buffered saline, and resuspended in a lysis buffer. The
suspensions were kept on ice for 30 min, and the lysate was collected
by centrifugation at l5,000 × g for 20 min at 4 °C.
Protein concentrations were determined using a Bradford assay. Extracts
were diluted to 1 mg/ml with lysis buffer. Immunoprecipitation with
anti-Cdk2 was performed by incubating 0.5 mg of extract and 4 µg of
antibody for 1 h at 4 °C. The immune complexes were then
incubated at 4 °C with 20 µl of a 50% suspension of protein
A-agarose and washed three times first with lysis buffer and then with
kinase buffer (l0 mM Tris, pH 7.4, 150 mM NaCl,
l0 mM MgCl2, and 0.5 mM
dithiothreitol) at 4 °C. The pellets were incubated for 15 min at
37 °C with 40 µl of the kinase assay buffer containing 25 µM ATP, 2.5 µCi of [32P]ATP, and histone
H1 at 1.0 mg/ml. 8 µl of 6× electrophoresis sample buffer was added
to 40 µl of the supernatant and boiled for 5 min and run on a 12.5%
SDS-polyacrylamide gel. The gel was fixed and stained with 0.25%
Coomassie Blue (in 45% methanol, 10% acetic acid), destained (40%
methanol, 10% acetic acid), dried, and exposed to x-ray film. For
quantification, the histone H1 bands were excised and 32P
incorporation was determined by liquid scintillation counting. The
amount of Cdk2 protein was determined by Western analysis.
Phosphorylation Assay--
The purified catalytic subunit of
rabbit skeletal muscle PP1c/ (19) (1.6 µg) was incubated for 30 min at 30 °C with varying concentrations of purified Cdk2/cyclin A
kinase in a total volume of 40 µl of kinase buffer (10 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM
MgCl2, 0.5 mM dithiothreitol, and 0.1 mM ATP). An aliquot of the reaction mixture was added to
6× sample buffer and heated at 100 °C for 4 min and resolved by
12% SDS-PAGE. Phosphorylated PP1c and PP1c were analyzed by Western analysis.
To assay the ability of endogenous Cdk2 to phosphorylate the Thr-320
site in PP1c, Jurkat cells were subjected to 10 Gy, and Cdk2 was
immunoprecipitated from 0.5 mg of cellular extract at various times
post-IR with 4 µg of Cdk2 antibody. The immunoprecipitates were
washed three times with ice-cold lysis buffer and three times with
ice-cold kinase buffer without ATP and then incubated with purified
catalytic subunit of rabbit skeletal muscle PP1c (1.6 µg) at 30 °C
for 45 min in a total volume of 40 µl of kinase buffer. Phosphorylated and total PP1c from the supernatant and Cdk2 in the
pellet were analyzed by immunoblot analysis.
PP1 Activity Assay--
PP1 was immunoprecipitated with 5 µg
of anti-PP1c monoclonal antibody from either an aliquot of the purified
PP1c-Cdk2 reaction mixture (0.5 µg of PP1c diluted in 1 ml of PP1
activity lysis buffer (see "Preparation of Nuclear Extracts")) or
from nuclear lysis solution (1.0 mg of nuclear protein) prepared from
Jurkat, FT/pEBS7, and FT/pEBS7-YZ5. The immune complexes were then
incubated with 30 µl of a 50% suspension of protein A-agarose beads
washed three times with ice-cold lysis buffer followed by ice-cold
Ser/Thr assay buffer (50 mM Tris-HCl, pH 7.0, 0.1 mM CaCl2). PP1 activity was assayed using a
Ser/Thr phosphatase assay kit (Upstate Biotechnology Inc.). The PP1
immune complex beads in 50 µl of Ser/Thr assay buffer were incubated
with the phosphopeptide KRpTIRR at 30 °C for 30 min. The beads were
pelleted, and 25 µl of supernatant was analyzed for free phosphate in
the malachite green assay by dilution with 100 µl of developing
solution (malachite green). After incubation for 15 min, the release of
phosphate was quantified by measuring the absorbance at 620 nm in a
microtiter plate reader.
 |
RESULTS |
IR Induces in Vivo Dephosphorylation of PP1--
We tested if
protein Ser/Thr phosphatases were targets of an IR-activated
damage-sensing pathway. Jurkat cells were labeled with inorganic
32P for 45 min after irradiation or sham irradiation.
Nuclear extracts were prepared and subjected to microcystin affinity
chromatography, followed by two-dimensional gel analysis (Fig.
1). Microcystin binds with nanomolar
affinity to the catalytic cleft of protein phosphatases (20) and can be
used to rapidly and quantitatively recover the various forms of PP1 and
PP2A from extracts (21) together with their multiple regulatory
subunits (22). On the two-dimensional gel, more than 50 distinct
silver-stained proteins were visualized in the elution from the
microcystin beads, and about a dozen of these were
32P-labeled. The levels of 32P incorporated
into one group of proteins retained by the microcystin matrix
dramatically decreased following IR, and we centered our attention on
these proteins (Fig. 1). The major form, both by silver staining and
32P labeling, was the protein in spot 3. However, all of
these spots were dephosphorylated in response to IR, based on
32P labeling. Tandem mass spectrometric sequencing revealed
these proteins were the and isoforms of PP1 (Table
I). The differences in migration in the
first dimension (isoelectric focusing) for these PP1 isoforms are
probably because of formation of intramolecular disulfides and/or
differences in oxidation state of the multiple Cys residues in the
catalytic subunits. Regardless, the results show IR caused loss of
32P indicating that PP1 is phosphorylated in living cells
and IR causes net dephosphorylation.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
IR dephosphorylates PP1 and .
Asynchronously growing Jurkat cells were subjected to either 0 or
10 Gy. Post-IR, the cells were labeled with
[32P]orthophosphate (0.6 mCi/ml) for 45 min after which
they were washed with cold phosphate-buffered saline. Extracts were
prepared and equal amounts of protein subjected to microcystin affinity
chromatography as previously described (38). The pellets were heated
with sample buffer and were subjected to two-dimensional gel
electrophoresis. The gels were then silver-stained and exposed to films
to make autoradiographs. The four proteins circled were
sequenced by tandem mass spectroscopy.
|
|
Effects of IR on Nuclear PP1 in Jurkat and AT Cells--
PP1 and isoforms contain a C-terminal RP(I/V)TPPR motif known to be a
preferred site for Cdk/Cdc phosphorylation (23). Phosphorylation of the
threonine in this motif occurs in yeast as well as mammalian PP1 (24)
and attenuates PP1 activity. We and others (25, 26) have shown that IR
inhibits Cdk2/cyclin A and Cdk2/cyclin E activity, and both of these
kinases phosphorylate PP1 at Thr-320. We reasoned that DNA damage
might activate PP1 through reduced phosphorylation of this Thr site.
Jurkat cells were irradiated and nuclear extracts were assayed for
phosphatase activity at various times post-IR (Fig.
2a). There was more than a
doubling in PP1 activity over 90 min. In parallel nuclear extracts were
subjected to immunoblot analysis with a phospho-PP1 (Thr-320) antibody. As shown in Fig. 2, a and b, 10 Gy
resulted in a time-dependent dephosphorylation of Thr-320
of PP1, which parallels the IR-induced increase in PP1 activity. PP1
levels themselves, which serve as a loading control, were unchanged,
arguing that there was increased specific activity, not synthesis or
import of PP1.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
a, IR activates nuclear PP1. Jurkat
cells (circles) were subjected to 10 Gy, and nuclear
extracts were prepared at various times post-IR. PP1c was then
immunoprecipitated, and its activity was measured using the
phosphopeptide substrate KRpTIRR as described under "Materials and
Methods." Quantitation (squares) of the optical density of
the immunoblot shown in b was measured by Image Quant 5.0 (Molecular Dynamics, Sunnyvale, CA). b, IR induces
dephosphorylation on Thr-320 of nuclear PP1 catalytic subunit.
Asynchronously growing Jurkat cells received either 0 or 10 Gy
irradiation, and nuclear extracts were prepared at the indicated times
post-IR and subjected to immunoblot analysis with phospho-PP1c
(Thr-320) and anti-PP1c.
|
|
To verify that Thr-320 phosphorylation regulates PP1 activity under our
assay conditions, purified skeletal muscle PP1 protein was incubated
with purified Cdk2 kinase and subjected to immunoprecipitation with
anti-PP1c. PP1 activity in the immunoprecipitates was assayed with a
phosphopeptide as substrate. As expected, increasing doses of Cdk2
resulted in increased phosphorylation of the Thr-320 site (Fig.
3a). Phosphorylation of this
site in PP1 corresponded to decreased PP1 activity (Fig.
3b). Thus, in vitro and in living cells the level
of Thr-320 phosphorylation inversely correlated with the specific
activity of PP1.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Thr-320 phosphorylation influences PP1
activity. Purified catalytic subunit of rabbit skeletal muscle PP1
was incubated for 30 min at 30 °C with the indicated concentrations
of purified Cdk2 kinase as described under "Materials and Methods."
a, an aliquot of the reaction mixture was subjected to
immunoblot analysis with phospho-PP1c/ Thr-320 antibody and
anti-PP1c. Quantitation (squares) of the optical density of
the immunoblot is shown in b. b, PP1c was
immunoprecipitated from the remaining reaction mixture and its activity
was measured as described for Fig. 2a.
|
|
To establish that IR inhibited the activity of the
endogenous Cdk2 kinase that was phosphorylating PP1, Cdk2 was
immunoprecipitated at various intervals after 10 Gy. As shown in Fig.
4, the activity of endogenous Cdk2 toward
PP1 at the Thr-320 site decreased in a time-dependent
manner following IR.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
IR decreases the ability of endogenous Cdk2
to phosphorylate the Thr-320 site in PP1c. Jurkat cells were
subjected to 10 Gy, and Cdk2 was immunoprecipitated from nuclear
extracts at various times post-IR. The pellet was incubated with
purified PP1c at 30 °C for 45 min as described under "Materials
and Methods." The supernatant was subjected to immunoblot analysis
with phospho-PP1c/ (Thr-320) antibody and anti-PP1c.
|
|
IR Both Decreases Cdk2 Kinase and Increases PP1 Phosphatase
Activity in an ATM-dependent Manner--
We previously
found that IR-induced dephosphorylation of histone H1 is
ATM-dependent (14). This is because of reduced Cdk2 kinase
and increased nuclear phosphatase activity. IR (10 Gy) inhibits Cdk2
activity in an ATM-dependent manner as shown in Fig.
5a. Cdk2 from AT (PEBS) cells
lacking active ATM kinase was inhibited only 40% whereas Cdk2 from
reconstituted AT cells (YZ-5) that express ATM was inhibited by 84%.
The radiation-induced dephosphorylation of PP1 Thr-320 was
ATM-dependent. We compared AT cells (PEBS) and AT cells
transfected with full-length ATM (YZ-5) that were irradiated with a
dose of 10 Gy. Nuclear extracts were subjected to immunoblot analysis
that showed IR failed to dephosphorylate PP1 Thr-320 in AT
cells (Fig. 5b). However, in AT cells transfected with
full-length ATM, IR-induced dephosphorylation of Thr-320 occurred
in a time-dependent manner starting ~15 min
post-irradiation. This genetic system was used to demonstrate that
IR-induced dephosphorylation of the Thr-320 site of PP1 is dependent on
ATM.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
IR-induced nuclear PP1c dephosphorylation and
activation are ATM-dependent. a, in
vitro H1 kinase activity was determined on immunoprecipitates with
antibodies to Cdk2 at various times following 10 Gy. All experiments
were performed 3 times with similar results, and a representative
experiment is shown. Equal loading of H1 and Cdk2 is shown as controls.
Percentage inhibition of kinase activity was determined by excising H1
bands from the gel and measuring 32P incorporation by
liquid scintillation counting. b, AT fibroblasts transfected
with either empty vector FT/pEBS7 (PEBS) or recombinant wild type
ATM FT/pEBS7-YZ5 (YZ-5) were irradiated with 10 Gy, and
nuclear extracts were subjected to immunoblot analysis with either a
phospho-PP1c (Thr-320) antibody or anti-PP1c. c, AT
fibroblasts PEBS and YZ-5 were irradiated with 10 Gy, and PP1c was
immunoprecipitated from nuclear extracts and assayed for PP1 activity
as described for Fig. 2a.
|
|
The ATM kinase is also necessary for the IR-induced increase in PP1
activity. Nuclear extracts were prepared from AT cells deficient in ATM
and AT cells expressing ectopic full-length ATM. Samples were subjected
to immunoprecipitation with anti-PP1 and assayed for PP1 activity. As
shown in Fig. 5c, the IR-induced time-dependent
2-fold increase in PP1 activity was only observed in cells expressing
ATM. Interestingly, the time course of IR activation of PP1 parallels
that of IR-induced H1 dephosphorylation, which we have
previously reported (14).
Three genes code for four distinct isoforms of PP1 in mammals called
, 1, 2, and (3). Using isoform-specific antibodies to
immunoprecipitate PP1c and from cell lysates, we tested if the
Thr-320 site was dephosphorylated in response to IR in Jurkat, AT, and
reconstituted AT cells. The numbering of the Thr-320 is not identical
in and but lies in the corresponding sequence motif in both
these PP1 isoforms. Consistent with the metabolic 32P-labeling results (Fig. 1), both the and PP1
isoforms were dephosphorylated at the Thr-320 site in
response to IR (Fig. 6a). Furthermore, the dephosphorylation of both the and isoforms was
ATM-dependent, as shown in Fig. 6b. Decreased
phosphospecific staining of PP1 and was only seen in irradiated
cells that were expressing ATM (YZ-5 clone). Cells that did not express
ATM (PEBS) did not show diminished phospho-Thr-320 staining in response to IR.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
IR-induced dephosphorylation of PP1
and PP1 is
ATM-dependent. Jurkat (a) and AT
fibroblasts PEBS and YZ-5 (b) were irradiated with 10 Gy.
Nuclear extracts were prepared and subjected to immunoprecipitation
with the indicated isoform-specific anti-PP1c antibodies.
Immunoblot analysis was performed as described for Fig. 2.
IP, immunoprecipitate.
|
|
 |
DISCUSSION |
IR is known to activate the G1, S, and G2
checkpoints (2, 27) in an ATM-dependent manner. The
ATM gene is mutated in the autosomal recessive disease
ataxia telangiectasia, characterized by neuronal degeneration resulting
in ataxia, oculocutaneous telangiectasia, immune dysfunction, and
cancer predisposition (28). ATM is thought to be an upstream sensor of
DNA damage as well as oxidative stress. ATM transmits the damage signal
downstream through its C-terminal phosphoinositol 3-kinase domain.
ATM has been shown to directly phosphorylate several proteins and to
enhance the phosphorylation of other proteins by activating downstream
protein kinases. These targets include the nuclear tyrosine kinase
c-Abl, Chk2, nibrin, p53, and BRCA1, all of which have been implicated
in DNA damage responses (29-33).
Interestingly, ATM has also been shown to control the damage-induced
dephosphorylation of Ser-376 in p53 (34) and to regulate H1
dephosphorylation following IR. Thus, ATM activates the phosphatase(s) responsible for dephosphorylating H1 and p53. We have recently demonstrated that IR causes dissociation of the B55 regulatory subunit, which has been implicated in mitotic progression, from heterotrimeric nuclear PP2A in an ATM-dependent manner
(38). Although the functional significance of IR-induced dissociation of B55 from PP2A heterotrimer is unknown, it is likely that
IR-induced subunit exchange allows PP2A to execute diverse functions in
the damage response. PP1 and PP2A are both downstream effectors of an
IR-activated and ATM-dependent signaling pathway. It seems likely that IR-induced PP1 activation as well as PP2A subunit exchange
requires the function of the kinase domain of ATM, but this remains to
be determined.
We imagine two potential but not mutually exclusive mechanisms by which
ATM could regulate PP1 activity. First, ATM is known to inhibit Cdc2
and Cdk2 in response to IR. The PP1 Thr-320 site is phosphorylated by
Cdc2/Cdk2. Thus, IR-activated ATM could increase PP1 activity
indirectly through inactivation of Cdc2/Cdk2 kinase, thereby decreasing
the phosphorylation of Thr-320. Because ATM has recently been shown to
regulate Cdc25A (the activator of Cdk2) through Chk2, it is possible
that ATM regulates PP1 through the Chk2-Cdc25A pathway. If this were
the case, then a dual specificity phosphatase (Cdc25) would be
regulating another phosphatase (PP1) via a
phosphatase-kinase-phosphatase cascade (Cdc25-Cdk2-PP1). Our data do
not establish that Cdk2 is the in vivo kinase of PP1. There
may be other kinases that phosphorylate the Thr-320 site in PP1, but
they would also need to be regulated in response to IR by an
ATM-dependent pathway. Alternatively, ATM could
directly (or indirectly) phosphorylate a nuclear PP1 subunit that
restrains PP1 in its phosphorylated, low activity form. Phosphorylation would release inhibition and allow autodephosphorylation of Thr-320 and
activation of PP1 toward other substrates. NIPP is one example of a
nuclear PP1 regulatory subunit whose activity is regulated by
phosphorylation (35, 36).
What are the downstream nuclear substrates of PP1 that may be critical
in the damage response? Unlike protein serine/threonine kinases, PP1
catalytic subunit does not manifest a high degree of sequence
specificity and dephosphorylates multiple substrates. The substrate
specificity of PP1 is thought to be modulated through the formation of
heterodimeric complexes with regulatory subunits. Regulatory proteins
that target PP1 to its substrates in response to DNA damage are not
known, and these may bind both and isoforms or there may be
individual regulatory subunits for these isoforms. Specific PP1
isoforms have been shown to have distinct functions and locations. For
example, the PP1 isoform has been shown to regulate the
G1/S transition by dephosphorylating Rb (12), and the
PP1 isoform is chromatin-associated. Because histone H1 and histone
H3 have been implicated as PP1 substrates (14, 16, 37), it is likely
that the PP1 isoform may regulate IR-induced H1 and H3 dephosphorylation.
In summary, the PP1 and isoforms are dynamically phosphorylated
in Jurkat cells and in response to IR become activated by
dephosphorylation of Thr-320 to function as a downstream effector of an
ATM-dependent damage-sensing pathway. Regardless of the mechanism by which ATM activates PP1, defining the regulatory subunits
that target PP1 to its respective substrates may reveal novel targets
for chemo and radiation sensitizers. Drugs that function at the level
of these targets may have low toxicity and, therefore, be more
efficacious than less specific inhibitors.
 |
FOOTNOTES |
*
This study was supported by National Institutes of Health
Grants CA 72622 (to J. M. L.) and GM 56362 and CA 40042 (to
D. L. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: University of
Virginia Health System, Box 800383, Charlottesville, VA
22908-0383. Tel.: 434-924-5191; Fax: 434-982-3262; E-mail:
jml2p@virginia.edu.
Published, JBC Papers in Press, August 28, 2002, DOI 10.1074/jbc.M207519200
 |
ABBREVIATIONS |
The abbreviations used are:
IR, ionizing
radiation;
PP1, protein phosphatase 1;
Gy, gray;
PMSF, phenylmethylsulfonyl fluoride.
 |
REFERENCES |
| 1.
|
Liu, V. F.,
Boubnov, N. V.,
and Weaver, D. T.
(1995)
Stem Cells
13 Suppl. 1,
117-128[Medline]
[Order article via Infotrieve]
|
| 2.
|
Larner, J. M.,
Lee, H.,
and Hamlin, J. L.
(1997)
Cancer Surv.
29,
25-45[Medline]
[Order article via Infotrieve]
|
| 3.
|
Cohen, P. T.
(2002)
J. Cell Sci.
115,
241-256[Abstract/Free Full Text]
|
| 4.
|
Clarke, P. R.,
Hoffmann, I.,
Draetta, G.,
and Karsenti, E.
(1993)
Mol. Biol. Cell
4,
397-411[Abstract]
|
| 5.
|
van Zyl, W.,
Huang, W.,
Sneddon, A. A.,
Stark, M.,
Camier, S.,
Werner, M.,
Marck, C.,
Sentenac, A.,
and Broach, J. R.
(1992)
Mol. Cell. Biol.
12,
4946-4959[Abstract/Free Full Text]
|
| 6.
|
Virshup, D. M.,
Russo, A. A.,
and Kelly, T. J.
(1992)
Mol. Cell. Biol.
12,
4883-4895[Abstract/Free Full Text]
|
| 7.
|
Ohkura, H.,
Kinoshita, N.,
Miyatani, S.,
Toda, T.,
and Yanagida, M.
(1989)
Cell
57,
997-1007[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Hughes, M.,
Arundhati, A.,
Lunness, P.,
Shaw, P. J.,
and Doonan, J. H.
(1996)
EMBO J.
15,
4574-4583[Medline]
[Order article via Infotrieve]
|
| 9.
|
Doonan, J. H.,
MacKintosh, C.,
Osmani, S.,
Cohen, P.,
Bai, G.,
Lee, E. Y.,
and Morris, N. R.
(1991)
J. Biol. Chem.
266,
18889-18894[Abstract/Free Full Text]
|
| 10.
|
Fernandez, A.,
Brautigan, D. L.,
and Lamb, N. J.
(1992)
J. Cell Biol.
116,
1421-1430[Abstract/Free Full Text]
|
| 11.
|
Tournebize, R.,
Andersen, S. S.,
Verde, F.,
Doree, M.,
Karsenti, E.,
and Hyman, A. A.
(1997)
EMBO J.
16,
5537-5549[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Berndt, N.,
Dohadwala, M.,
and Liu, C. W.
(1997)
Curr. Biol.
7,
375-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Thompson, L. J.,
Bollen, M.,
and Fields, A. P.
(1997)
J. Biol. Chem.
272,
29693-29697[Abstract/Free Full Text]
|
| 14.
|
Guo, C. Y.,
Wang, Y.,
Brautigan, D. L.,
and Larner, J. M.
(1999)
J. Biol. Chem.
274,
18715-18720[Abstract/Free Full Text]
|
| 15.
|
Guo, C. Y.,
Mizzen, C.,
Wang, Y.,
and Larner, J. M.
(2000)
Cancer Res.
60,
5667-5672[Abstract/Free Full Text]
|
| 16.
|
Murnion, M. E.,
Adams, R. R.,
Callister, D. M.,
Allis, C. D.,
Earnshaw, W. C.,
and Swedlow, J. R.
(2001)
J. Biol. Chem.
276,
26656-26665[Abstract/Free Full Text]
|
| 17.
|
Ziv, Y.,
Jaspers, N. G.,
Etkin, S.,
Danieli, T.,
Trakhtenbrot, L.,
Amiel, A.,
Ravia, Y.,
and Shiloh, Y.
(1989)
Cancer Res.
49,
2495-2501[Abstract/Free Full Text]
|
| 18.
|
Ziv, Y.,
Bar-Shira, A.,
Pecker, I.,
Russell, P.,
Jorgensen, T. J.,
Tsarfati, I.,
and Shiloh, Y.
(1997)
Oncogene
15,
159-167[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Martin, B. L.,
Shriner, C. L.,
and Brautigan, D. L.
(1994)
Protein Expression Purif.
5,
211-217[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Damer, C. K.,
Partridge, J.,
Pearson, W. R.,
and Haystead, T. A.
(1998)
J. Biol. Chem.
273,
24396-24405[Abstract/Free Full Text]
|
| 21.
|
Chung, H.,
Narin, A.,
Murata, K.,
and Brautigan, D. L.
(1999)
Biochemistry
38,
10371-10376[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Campos, M.,
Fadden, P.,
Alms, G.,
Qian, Z.,
and Haystead, T. J.
(1996)
J. Biol. Chem.
271,
28478-28484[Abstract/Free Full Text]
|
| 23.
|
Dohadwala, M.,
da Cruz e Silva, E. F.,
Hall, F. L.,
Williams, R. T.,
Carbonaro-Hall, D. A.,
Nairn, A. C.,
Greengard, P.,
and Berndt, N.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6408-6412[Abstract/Free Full Text]
|
| 24.
|
Yamano, H.,
Ishii, K.,
and Yanagida, M.
(1994)
EMBO J.
13,
5310-5318[Medline]
[Order article via Infotrieve]
|
| 25.
|
D'Anna, J. A.,
Valdez, J. G.,
Habbersett, R. C.,
and Crissman, H. A.
(1997)
Radiat. Res.
148,
260-271[Medline]
[Order article via Infotrieve]
|
| 26.
|
Guo, C. Y.,
D'Anna, J. A., Li, R.,
and Larner, J. M.
(1999)
Radiat. Res.
151,
125-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Beamish, H.,
Williams, R.,
Chen, P.,
and Lavin, M. F.
(1996)
J. Biol. Chem.
271,
20486-20493[Abstract/Free Full Text]
|
| 28.
|
Lavin, M. F.,
and Shiloh, Y.
(1996)
Curr. Opin. Immunol.
8,
459-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Shafman, T.,
Khanna, K. K.,
Kedar, P.,
Spring, K.,
Kozlov, S.,
Yen, T.,
Hobson, K.,
Gatei, M.,
Zhang, N.,
Watters, D.,
Egerton, M.,
Shiloh, Y.,
Kharbanda, S.,
Kufe, D.,
and Lavin, M. F.
(1997)
Nature
387,
520-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Matsuoka, S.,
Huang, M.,
and Elledge, S. J.
(1998)
Science
282,
1893-1897[Abstract/Free Full Text]
|
| 31.
|
Gatei, M.,
Young, D.,
Cerosaletti, K. M.,
Desai-Mehta, A.,
Spring, K.,
Kozlov, S.,
Lavin, M. F.,
Gatti, R. A.,
Concannon, P.,
and Khanna, K.
(2000)
Nat. Genet.
25,
115-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Khanna, K. K.,
Keating, K. E.,
Kozlov, S.,
Scott, S.,
Gatei, M.,
Hobson, K.,
Taya, Y.,
Gabrielli, B.,
Chan, D.,
Lees-Miller, S. P.,
and Lavin, M. F.
(1998)
Nat. Genet.
20,
398-400[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Gatei, M.,
Zhou, B. B.,
Hobson, K.,
Scott, S.,
Young, D.,
and Khanna, K. K.
(2001)
J. Biol. Chem.
276,
17276-17280[Abstract/Free Full Text]
|
| 34.
|
Waterman, M. J.,
Stavridi, E. S.,
Waterman, J. L.,
and Halazonetis, T. D.
(1998)
Nat. Genet.
19,
175-178[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Vulsteke, V.,
Beullens, M.,
Waelkens, E.,
Stalmans, W.,
and Bollen, M.
(1997)
J. Biol. Chem.
272,
32972-32978[Abstract/Free Full Text]
|
| 36.
|
Van Eynde, A.,
Wera, S.,
Beullens, M.,
Torrekens, S.,
Van Leuven, F.,
Stalmans, W.,
and Bollen, M.
(1995)
J. Biol. Chem.
270,
28068-28074[Abstract/Free Full Text]
|
| 37.
|
Paulson, J. R.,
Patzlaff, J. S.,
and Vallis, A. J.
(1996)
J. Cell Sci.
109,
1437-1447[Abstract]
|
| 38.
|
Guo, C. Y.,
Brautigan, D. L.,
and Larner, J. M.
(2002)
J. Biol. Chem.
277,
4839-4844[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Mi, E. Bolesta, D. L. Brautigan, and J. M. Larner
PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53
Mol. Cancer Ther.,
January 1, 2009;
8(1):
135 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Tang, Z.-g. Hui, X.-l. Cui, R. Garg, M. B. Kastan, and B. Xu
A Novel ATM-Dependent Pathway Regulates Protein Phosphatase 1 in Response to DNA Damage
Mol. Cell. Biol.,
April 15, 2008;
28(8):
2559 - 2566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mi, C. Guo, D. L. Brautigan, and J. M. Larner
Protein Phosphatase-1{alpha} Regulates Centrosome Splitting through Nek2
Cancer Res.,
February 1, 2007;
67(3):
1082 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Dong and A. E. Tomkinson
ATM mediates oxidative stress-induced dephosphorylation of DNA ligase III{alpha}
Nucleic Acids Res.,
November 6, 2006;
34(20):
5721 - 5279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Prickett and D. L. Brautigan
Overlapping Binding Sites in Protein Phosphatase 2A for Association with Regulatory A and {alpha}-4 (mTap42) Subunits
J. Biol. Chem.,
September 10, 2004;
279(37):
38912 - 38920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, J. Guan, B. Hu, R. S. Weiss, G. Iliakis, and Y. Wang
Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiation
Nucleic Acids Res.,
February 3, 2004;
32(2):
767 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. CEULEMANS and M. BOLLEN
Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button
Physiol Rev,
January 1, 2004;
84(1):
1 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes
ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses
Carcinogenesis,
October 1, 2003;
24(10):
1571 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang and D. L. Brautigan
A Novel Transmembrane Ser/Thr Kinase Complexes with Protein Phosphatase-1 and Inhibitor-2
J. Biol. Chem.,
December 13, 2002;
277(51):
49605 - 49612.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|